
Making sense of dysautonomia, PoTS and Long COVID science one decoded article at a time.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 90 | Founded | 7 months ago | Last Issue | 6 days ago |
| Active | |||||

The Stanford team behind the original ME/CFS findings just published their Long COVID cohort. Five years of community data, one retrospective study...Here is what it actually shows.
If you have spent any time in ME/CFS or Long COVID patien...
Most people who know fluvoxamine know it as an SSRI. It is prescribed for OCD, sometimes for depression, and it has been around long enough that it carries the vague familiarity of a drug nobody finds particularly exciting. If you have spen...
The Dysautonomia Decoded trial database covering PoTS, Long COVID, ME/CFS, EDS, MCAS and FND has been updated for November.
Today let’s look at what’s new in the tracker this month.
Today let’s decode a study that has been sitting at the top of my reading list for weeks. Published in PLOS Digital Health in November 2026, it is the largest real-world characterisation of hEDS ever conducted. Its findings matter enormousl...
Part One covered why sleep fails in autonomic dysfunction. This is the action piece. The interventions backed by real evidence and what to bring to a specialist.
Today we are decoding what you can actually do about dysautonomia sleep. This...
Subscribers, engagement, traffic and sponsorship for Dysautonomia Decoded.
| Subscribers | Engagement | 84 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #84 | |
| #52 |
The writers behind this newsletter.
Hi, I'm Meg. PhD in neuroscience, researcher by day, and apparently now the person who reads every PoTS, Long-Covid, dysautonomia paper so you don't have to. New pieces weekly.
You can find recent issues that have been published by Dysautonomia Decoded on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Dysautonomia Decoded, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Dysautonomia Decoded as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Dysautonomia Decoded using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Dysautonomia Decoded. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.